Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status
出版年份 2019 全文链接
标题
Real-world treatment patterns and healthcare costs of biologics and apremilast among patients with moderate-to-severe plaque psoriasis by metabolic condition status
作者
关键词
-
出版物
JOURNAL OF DERMATOLOGICAL TREATMENT
Volume -, Issue -, Pages 1-9
出版商
Informa UK Limited
发表日期
2019-11-26
DOI
10.1080/09546634.2019.1698699
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Secukinumab Drug Survival in Patients with Psoriasis: A multicenter, real-world, retrospective study
- (2019) Tiago Torres et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Comment on “Secukinumab Drug Survival in Patientes with Psoriasis: A multicenter, real-world, retrospective study”
- (2019) Laura Palacios-García et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Characterization of responder groups to secukinumab treatment in moderate to severe plaque psoriasis
- (2019) Andreas Pinter et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Tildrakizumab Efficacy and Safety Are Not Altered by Metabolic Syndrome Status in Patients With Psoriasis: Post Hoc Analysis of 2 Phase 3 Randomized Controlled Studies (reSURFACE 1 and reSURFACE 2)
- (2019) Mark G. Lebwohl et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study
- (2018) M. Talamonti et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study
- (2018) J.M. Fernández-Armenteros et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Position Statement for the Management of Comorbidities in Psoriasis
- (2018) E Dauden et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Treatment Changes in Patients With Moderate to Severe Psoriasis: A Retrospective Chart Review
- (2017) Jaclyn A. Smith et al. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
- Serum levels of adipokines and cytokines in psoriasis patients: a systematic review and meta-analysis
- (2017) Fan Bai et al. Oncotarget
- An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies
- (2017) Sanminder Singh et al. PLoS One
- Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis
- (2015) Arnd Jacobi et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Prevalence of the Metabolic Syndrome in the United States, 2003-2012
- (2015) Maria Aguilar et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Economic and Comorbidity Burden Among Patients with Moderate-to-Severe Psoriasis
- (2015) Steven R. Feldman et al. Journal of Managed Care & Specialty Pharmacy
- Patterns of Medication Utilization and Costs Associated with the Use of Etanercept, Adalimumab, and Ustekinumab in the Management of Moderate-to-Severe Psoriasis
- (2015) Steven R. Feldman et al. Journal of Managed Care & Specialty Pharmacy
- Psoriasis prevalence among adults in the United States
- (2014) Tara D. Rachakonda et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Undertreatment, Treatment Trends, and Treatment Dissatisfaction Among Patients With Psoriasis and Psoriatic Arthritis in the United States
- (2013) April W. Armstrong et al. JAMA Dermatology
- Kinetics of circulating Th17 cytokines and adipokines in psoriasis patients
- (2011) Hideki Nakajima et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Impact of body mass index on retention rates of anti-TNF-alfa drugs in daily practice for psoriasis
- (2011) Vito Di Lernia et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Prevalence of the Metabolic Syndrome in Psoriasis
- (2010) Thorvardur Jon Love et al. ARCHIVES OF DERMATOLOGY
- Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model
- (2010) Jürgen Scholze et al. BMC PUBLIC HEALTH
- Prevalence Rates and Costs of Metabolic Syndrome and Associated Risk Factors Using Employeesʼ Integrated Laboratory Data and Health Care Claims
- (2010) Howard G. Birnbaum et al. JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE
- A comprehensive definition for metabolic syndrome
- (2009) P. L. Huang Disease Models & Mechanisms
- Anti–tumour necrosis factor-α therapy increases body weight in patients with chronic plaque psoriasis: a retrospective cohort study
- (2008) P Gisondi et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Medication Compliance and Persistence: Terminology and Definitions
- (2007) Joyce A. Cramer et al. VALUE IN HEALTH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started